Cardiovascular evaluation of tiotropium during constant-work rate exercise in COPD Source: Eur Respir J 2003; 22: Suppl. 45, 49s Year: 2003
Association of heart rate recovery after exercise test with exercise capacity in patients with stable COPD Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation Year: 2013
Heart rate recovery after 6-min walk test predicts acute exacerbation in COPD Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013
Improvements in inspiratory capacity with tiotropium in patients with COPD Source: Eur Respir J 2002; 20: Suppl. 38, 491s Year: 2002
Metronome-paced hyperventilation, CT measurements and exercise to investigate dynamic hyperinflation contrasting tiotropium versus indacaterol treatment in moderate COPD patients Source: International Congress 2015 – Unravelling the mechanisms of symptoms and exercise limitationas in disease Year: 2015
Heart rate variability in patients with asthma and symptomatic hypertension Source: Eur Respir J 2003; 22: Suppl. 45, 478s Year: 2003
Mechanisms of improved exercise tolerance in COPD in response to tiotropium Source: Eur Respir J 2002; 20: Suppl. 38, 288s Year: 2002
Effect of olodaterol once-daily on heart rate in GOLD 2–4 COPD patients Source: International Congress 2017 – COPD management Year: 2017
Baseline characteristics of COPD patients with frequent COPD exacerbations in tiotropium trials Source: Eur Respir J 2006; 28: Suppl. 50, 175s Year: 2006
Effects of inhaled furosemide on exercise capacity and on dyspnea in patients with COPD Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis Year: 2015
Formoterol given either alone or together with tiotropium, reduces the rate of exacerbations in stable COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 430s Year: 2006
Ventilatory response to exercise in patients with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 108s Year: 2005
Resting heart rate and exacerbations in COPD patients Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016
Cardiovascular safety of salmeterol in patients with COPD Source: Eur Respir J 2002; 20: Suppl. 38, 240s Year: 2002
Effects of tiotropium on neurohumoral activation during exercise in stable COPD patients Source: Annual Congress 2009 - Next generation bronchodilators Year: 2009
Respiratory timing and dynamic hyperinflation during incremental exercise in patients with COPD Source: International Congress 2016 – Unmasking the mechanisms of symptoms and exercise limitation in disease Year: 2016
Cardiovascular limitation to exercise in COPD patients Source: Annual Congress 2010 - Gas exchange and paediatric exercise testing Year: 2010
Dual bronchodilation with once-daily QVA149 improves lung function and reduces exacerbations in patients with COPD: The IGNITE trials Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs Year: 2013
The fixed-dose combination of tiotropium + olodaterol has a rapid onset of action in patients with COPD Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis Year: 2015
Acute bronchodilator response does not predict health outcomes in patients with COPD treated with tiotropium Source: Annual Congress 2009 - Next generation bronchodilators Year: 2009